Weave Communications, Inc. (WEAV) Stock Analysis and Metrics

Weave Communications

NYSE: WEAV

$6.17 ▲ +0.21 (+3.52%)

At close: Jul 24, 2026 · 3:59 PM UTC

Financial Ratios

Market Cap468.33 Mn

P/E-18.72

P/S1.88

Div. Yield0.00

ROIC (Qtr)0.00

Revenue Growth (1y) (Qtr)17.36

Add ratio to table…

About

Weave Communications, Inc. provides an AI powered patient communications, engagement, and payments platform designed specifically for small and medium sized healthcare practices. The company unifies voice, text, and AI driven workflows into a single system that helps practices manage patient interactions, streamline operations, and improve revenue cycle performance. Its platform integrates with over 90 practice management systems and serves dental, optometry, veterinary, and specialty medical providers across the United States and Canada. Weave’s mission is to elevate the patient experience through a unified platform that improves business operations so healthcare professionals can focus on patient care and realize their dreams. The platform brings together voice, text, and AI powered workflows into a single system of work, enabling practices to consolidate essential tools such as appointment scheduling, payment processing, and patient outreach.

Weave Communications, Inc. generates revenue primarily through subscription fees for its unified platform, which includes modules such as AI receptionist, unified phone number, text messaging, payment processing, digital forms, online scheduling, and analytics. Customers pay recurring fees for access to these tools, and the company also earns transaction based revenue from its payment processing services. Subscription plans are tiered based on the number of provider locations and the selected feature set, allowing practices to scale usage as they grow. In addition to core communications, the company offers specialized products such as AI powered call intelligence, patient financing options through partners, and reputation management tools that help collect and respond to online reviews. The company's customer base consists of tens of thousands of small and medium sized healthcare practices in the United States and Canada.

Weave Communications, Inc. operates in a highly fragmented market for healthcare practice software where many competitors offer only point solutions such as messaging, payment processing, or reputation management. The company differentiates itself by delivering an all in one vertically integrated platform that combines communications, AI powered workflows, and payment processing within a single interface. Its competitive advantages include deep integration with over 90 practice management systems, proprietary cloud based phone hardware, industry specific workflows for dental, optometry, veterinary, and specialty medical settings, and a focus on ease of use for practices without dedicated IT staff. Weave also emphasizes rapid deployment, continuous product updates driven by its AI research, and a commitment to data security and compliance with healthcare privacy regulations. By providing a comprehensive solution that reduces the need for multiple vendors, Weave aims to lower total cost of ownership while improving patient engagement and practice efficiency.

Weave Communications, Inc. serves approximately 30,000 customers representing nearly 40,000 locations across the United States and Canada as of December 31, 2025. The majority of these customers are dental practices, optometry clinics, veterinary hospitals, and specialty medical offices such as primary care, physical therapy, aesthetics, and med spas. No single customer accounts for more than 5% of the company's total revenue. The customer base includes solo practitioners, multi location groups, and dental service organizations. The platform is designed to support the unique workflows of each specialty, such as insurance eligibility verification for dental and eyewear ready notifications for optometry.

Investment Thesis

▲ Bull case

Weave Communications' strategic integration of Google Cloud's Gemini Enterprise Agent Platform represents a significant, underappreciated catalyst that will substantially enhance the capability and stickiness of its Omnichannel AI Receptionist beyond what was discussed in the earnings call. This partnership provides access to state-of-the-art multimodal AI that enables more natural, context-preserving conversations across voice and text channels, which directly addresses the core pain point of disconnected patient interactions highlighted by management. The enterprise-grade nature of this technology positions Weave to serve larger healthcare organizations and Dental Service Organizations (DSOs) more effectively, a segment where sales cycles are longer but lifetime value is substantially higher. Management did not emphasize how this advancement reduces the need for extensive custom integrations, potentially accelerating deployment and improving gross margins through lower implementation costs. The collaboration also validates Weave's technical approach in the eyes of enterprise clients, creating a credible pathway to upsell existing SMB customers to higher-tier solutions as their practices grow or consolidate, thereby expanding the addressable market beyond the current 40,000 location base. This enterprise AI foundation could unlock new pricing tiers and consumption-based revenue streams that were not fully articulated in the hybrid subscription model discussed during the call, potentially driving faster expansion of average revenue per location than currently modeled.
The company's payments revenue growth, which exceeded twice the rate of total revenue in Q1, contains a hidden structural driver in the form of surcharging adoption that management acknowledged as a 'very strong quarter' but did not frame as a potential long-term margin expansion lever. Surcharging allows practices to pass payment processing fees to patients, effectively increasing Weave's net take on transactions without raising its own prices, thereby improving the contribution margin of its payments business beyond the already expanding 78.4% subscription and payments margin. This dynamic is particularly powerful in an inflationary environment where healthcare providers face rising costs, as it creates a self-reinforcing cycle: higher transaction volumes driven by AI-led intake improvements (like the AI receptionist reducing missed calls) generate more surcharge revenue, which can be reinvested into product development. Management noted the integration of payment workflows with the AI receptionist as a future opportunity but did not quantify how surcharging could scale with increased AI-handled interactions, creating a hidden flywheel where better front-office automation directly increases payment processing volume and profitability. The ability to monetize surcharging at scale represents a less-discussed but high-leverage path to achieving the long-term gross margin target of 75% to 80% faster than anticipated, especially as more practices adopt omnichannel communication tools that capture previously lost revenue opportunities.
Weave's focus on becoming the 'control point' for practice communication and automation workflows through its extensive library of authorized practice management system integrations is an underappreciated moat that creates significant switching costs and positions the platform as indispensable infrastructure. While management mentioned having the 'largest library of authorized integrations,' they did not connect this to the network effects that emerge as more practice management systems certify with Weave, making it progressively harder for competitors to replicate the seamless data flow required for advanced AI functionality like intelligent handoffs and context preservation across channels. This integration depth enables the AI receptionist to not only schedule appointments but also trigger automated insurance eligibility checks and payment collection workflows in real time, creating a compounding value proposition that grows with each new integration. The omission of discussion around how this integration advantage lowers customer acquisition cost over time—by reducing implementation friction and increasing referral rates from practice management vendors—represents a missed insight into the scalability of their go-to-market model. As AI features become more deeply embedded in workflows, the platform's role transitions from a communication tool to a central operating system, increasing customer lifetime value and reducing sensitivity to price changes, which is critical for sustaining growth in the competitive healthcare SaaS landscape.

Weave Communications' strategic integration of Google Cloud's Gemini Enterprise Agent Platform represents a significant, underappreciated catalyst that will substantially enhance the capability and stickiness of its Omnichannel AI Receptionist beyond what was discussed in the earnings call. This partnership provides access to state-of-the-art multimodal AI that enables more natural, context-preserving conversations across voice and text channels, which directly addresses the core pain point of disconnected patient interactions highlighted by management. The enterprise-grade nature of this technology positions Weave to serve larger healthcare organizations and Dental Service Organizations (DSOs) more effectively, a segment where sales cycles are longer but lifetime value is substantially higher. Management did not emphasize how this advancement reduces the need for extensive custom integrations, potentially accelerating deployment and improving gross margins through lower implementation costs. The collaboration also validates Weave's technical approach in the eyes of enterprise clients, creating a credible pathway to upsell existing SMB customers to higher-tier solutions as their practices grow or consolidate, thereby expanding the addressable market beyond the current 40,000 location base. This enterprise AI foundation could unlock new pricing tiers and consumption-based revenue streams that were not fully articulated in the hybrid subscription model discussed during the call, potentially driving faster expansion of average revenue per location than currently modeled.
The company's payments revenue growth, which exceeded twice the rate of total revenue in Q1, contains a hidden structural driver in the form of surcharging adoption that management acknowledged as a 'very strong quarter' but did not frame as a potential long-term margin expansion lever. Surcharging allows practices to pass payment processing fees to patients, effectively increasing Weave's net take on transactions without raising its own prices, thereby improving the contribution margin of its payments business beyond the already expanding 78.4% subscription and payments margin. This dynamic is particularly powerful in an inflationary environment where healthcare providers face rising costs, as it creates a self-reinforcing cycle: higher transaction volumes driven by AI-led intake improvements (like the AI receptionist reducing missed calls) generate more surcharge revenue, which can be reinvested into product development. Management noted the integration of payment workflows with the AI receptionist as a future opportunity but did not quantify how surcharging could scale with increased AI-handled interactions, creating a hidden flywheel where better front-office automation directly increases payment processing volume and profitability. The ability to monetize surcharging at scale represents a less-discussed but high-leverage path to achieving the long-term gross margin target of 75% to 80% faster than anticipated, especially as more practices adopt omnichannel communication tools that capture previously lost revenue opportunities.
Weave's focus on becoming the 'control point' for practice communication and automation workflows through its extensive library of authorized practice management system integrations is an underappreciated moat that creates significant switching costs and positions the platform as indispensable infrastructure. While management mentioned having the 'largest library of authorized integrations,' they did not connect this to the network effects that emerge as more practice management systems certify with Weave, making it progressively harder for competitors to replicate the seamless data flow required for advanced AI functionality like intelligent handoffs and context preservation across channels. This integration depth enables the AI receptionist to not only schedule appointments but also trigger automated insurance eligibility checks and payment collection workflows in real time, creating a compounding value proposition that grows with each new integration. The omission of discussion around how this integration advantage lowers customer acquisition cost over time—by reducing implementation friction and increasing referral rates from practice management vendors—represents a missed insight into the scalability of their go-to-market model. As AI features become more deeply embedded in workflows, the platform's role transitions from a communication tool to a central operating system, increasing customer lifetime value and reducing sensitivity to price changes, which is critical for sustaining growth in the competitive healthcare SaaS landscape.

▼ Bear case

Despite management's optimism about AI-driven revenue retention expansion, the Q1 results show a concerning divergence where dollar-based net revenue retention (NRR) improved only to 92% while gross revenue retention remained at 89%, indicating that expansion revenue from upsells is not yet meaningfully contributing to offset churn—a dynamic management acknowledged by noting NRR 'may continue to land heavy' as new customers adopt products. The improvement in NRR appears driven more by stabilization in the existing base than by successful land-and-expand motions, particularly given that the company added a record number of new locations in the quarter, which typically dilutes NRR metrics in the short term due to lower initial spending and higher early-stage churn risk. Management's reliance on the long-term growth of average revenue per location (which has grown ~10% over two years) as a offset to declining NRR trends is risky, as it assumes continuous successful upsell execution without providing evidence of improving attachment rates for higher-margin AI products like Call Intelligence or the AI receptionist beyond early pilot successes. The fact that more than 50% of locations use at least one embedded AI feature suggests penetration is still incomplete, and without clear data on conversion rates from core bundles to paid AI add-ons, the market may be overestimating the scalability of the upsell motion, especially as sales and marketing expenses remain elevated at 40.6% of revenue with no clear timeline for efficiency gains.
The company's negative free cash flow of $7.1 million in Q1, attributed to seasonal factors like annual bonuses and prepaid renewals, masks an underlying concern about the quality of earnings, as operating cash flow was also negative at $5.7 million despite positive operating income of $2.5 million. This working capital outflow—driven by increased accounts receivable or deferred revenue timing—suggests that revenue recognition may be accelerating ahead of cash collection, a risk amplified by the growth in payments revenue and surcharging adoption, which could extend days sales outstanding if patient payment collection lags. Management did not address whether the seasonal disbursements were truly non-recurring or if similar outflows (e.g., equity settlements for RSU vests consuming $1.6 million in cash) could become more frequent as the employee base grows with sales and marketing headcount increases. The expectation for positive free cash flow in February 2026 relies heavily on the absence of these one-time items, but with sales and marketing expenses increasing year over year due to advertising and team expansions, there is a risk that operating expenses continue to rise as a percentage of revenue, squeezing the conversion of revenue growth into actual cash generation. This is particularly concerning given the company's history of meeting or exceeding revenue guidance but not consistently translating that into free cash flow, which could limit its ability to fund AI-related R&D investments without dilution.
While Weave emphasizes its purpose-built healthcare focus and deep workflow expertise as a competitive advantage, the rapid advancement of horizontal AI platforms like Google's Gemini—now directly integrated into Weave's offering—creates a strategic vulnerability where the company's proprietary differentiation could erode over time. By leaning on Google Cloud's enterprise-grade AI for the core natural language processing and contextual understanding of its Omnichannel AI Receptionist, Weave risks becoming primarily an integration and workflow orchestration layer rather than a true AI innovator, making its technology more susceptible to replication by competitors who could partner with similar cloud providers or leverage open-source models. Management did not discuss how they protect or monetize the healthcare-specific data and workflow insights that guide their AI application, raising concerns about the sustainability of their edge if the underlying AI models become commoditized. Furthermore, the heavy reliance on a single cloud provider for critical AI functionality introduces concentration risk; any disruption in Google Cloud services or changes in pricing/terms could disproportionately impact Weave's product performance and cost structure, especially as AI handling of interactions grew over 300% year over year. This dependency could constrain pricing flexibility and increase vulnerability to competition from platforms offering more modular or multi-cloud AI solutions, particularly as larger healthcare systems demand greater control over their AI vendors and data governance.

Despite management's optimism about AI-driven revenue retention expansion, the Q1 results show a concerning divergence where dollar-based net revenue retention (NRR) improved only to 92% while gross revenue retention remained at 89%, indicating that expansion revenue from upsells is not yet meaningfully contributing to offset churn—a dynamic management acknowledged by noting NRR 'may continue to land heavy' as new customers adopt products. The improvement in NRR appears driven more by stabilization in the existing base than by successful land-and-expand motions, particularly given that the company added a record number of new locations in the quarter, which typically dilutes NRR metrics in the short term due to lower initial spending and higher early-stage churn risk. Management's reliance on the long-term growth of average revenue per location (which has grown ~10% over two years) as a offset to declining NRR trends is risky, as it assumes continuous successful upsell execution without providing evidence of improving attachment rates for higher-margin AI products like Call Intelligence or the AI receptionist beyond early pilot successes. The fact that more than 50% of locations use at least one embedded AI feature suggests penetration is still incomplete, and without clear data on conversion rates from core bundles to paid AI add-ons, the market may be overestimating the scalability of the upsell motion, especially as sales and marketing expenses remain elevated at 40.6% of revenue with no clear timeline for efficiency gains.
The company's negative free cash flow of $7.1 million in Q1, attributed to seasonal factors like annual bonuses and prepaid renewals, masks an underlying concern about the quality of earnings, as operating cash flow was also negative at $5.7 million despite positive operating income of $2.5 million. This working capital outflow—driven by increased accounts receivable or deferred revenue timing—suggests that revenue recognition may be accelerating ahead of cash collection, a risk amplified by the growth in payments revenue and surcharging adoption, which could extend days sales outstanding if patient payment collection lags. Management did not address whether the seasonal disbursements were truly non-recurring or if similar outflows (e.g., equity settlements for RSU vests consuming $1.6 million in cash) could become more frequent as the employee base grows with sales and marketing headcount increases. The expectation for positive free cash flow in February 2026 relies heavily on the absence of these one-time items, but with sales and marketing expenses increasing year over year due to advertising and team expansions, there is a risk that operating expenses continue to rise as a percentage of revenue, squeezing the conversion of revenue growth into actual cash generation. This is particularly concerning given the company's history of meeting or exceeding revenue guidance but not consistently translating that into free cash flow, which could limit its ability to fund AI-related R&D investments without dilution.
While Weave emphasizes its purpose-built healthcare focus and deep workflow expertise as a competitive advantage, the rapid advancement of horizontal AI platforms like Google's Gemini—now directly integrated into Weave's offering—creates a strategic vulnerability where the company's proprietary differentiation could erode over time. By leaning on Google Cloud's enterprise-grade AI for the core natural language processing and contextual understanding of its Omnichannel AI Receptionist, Weave risks becoming primarily an integration and workflow orchestration layer rather than a true AI innovator, making its technology more susceptible to replication by competitors who could partner with similar cloud providers or leverage open-source models. Management did not discuss how they protect or monetize the healthcare-specific data and workflow insights that guide their AI application, raising concerns about the sustainability of their edge if the underlying AI models become commoditized. Furthermore, the heavy reliance on a single cloud provider for critical AI functionality introduces concentration risk; any disruption in Google Cloud services or changes in pricing/terms could disproportionately impact Weave's product performance and cost structure, especially as AI handling of interactions grew over 300% year over year. This dependency could constrain pricing flexibility and increase vulnerability to competition from platforms offering more modular or multi-cloud AI solutions, particularly as larger healthcare systems demand greater control over their AI vendors and data governance.

Segments Breakdown of Revenue (2025)

Peer Comparison

Companies in the Health Information Services

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	VEEV	Veeva Systems Inc	29.34 Bn	31.16	8.84	-
2	BTSG	BrightSpring Health Services, Inc.	13.49 Bn	46.18	0.99	2.50 Bn
3	HQY	Healthequity, Inc.	7.96 Bn	34.51	5.95	0.94 Bn
4	TXG	10x Genomics, Inc.	6.17 Bn	-272.14	9.65	-
5	HNGE	Hinge Health, Inc.	6.02 Bn	-11.77	9.31	-
6	MMED	MiniMed Group, Inc.	4.19 Bn	-8.88	1.38	-
7	WAY	Waystar Holding Corp.	4.14 Bn	32.80	3.58	1.47 Bn
8	DOCS	Doximity, Inc.	3.82 Bn	19.51	5.93	-

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Product and Service Breakdown of Revenue (2025)

Segments Breakdown of Revenue (2025)

Peer Comparison

Create an account

Sign In

Reset Password